Drug Pipeline

Onvansertib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06106308 Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and… Metastatic Colorectal Cancer Active, Not Recruiting
Phase 1/2
NCT05383196 Onvansertib + Paclitaxel In TNBC Breast Cancer Active, Not Recruiting
Phase 1
NCT05549661 Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia… Recurrent Chronic Myelomonocytic Leukemia Recruiting
Early Phase 1
NCT04005690 Targeted Pathway Inhibition in Patients With Pancreatic Cancer Locally Advanced Pancreatic Ductal Adenocarcinoma Recruiting
Sponsors Running Onvansertib Trials
OHSU Knight Cancer Institute (1) Antonio Giordano, MD (1) Mayo Clinic (1) Cardiff Oncology (1)
Disease Areas
Pancreatic Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Leukemia (1) Chronic Myeloid Leukemia (CML) (1) Myelodysplastic Syndromes (MDS) (1) Myelofibrosis (1) Colorectal Cancer (1)
Get alerts when Onvansertib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free